Missing/wrong data?
Log in to edit
Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial
scientific article published on 05 July 2015
Author/s
author: Jean-Charles Soria, Bushi Wang, Alessandro Morabito, Enriqueta Felip, Andrea Ardizzoni, Glenwood D Goss
Work details
Publication date
July 5, 2015
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.